Recent Finacing
Recent Raise
Attralus is a clinical-stage biopharmaceutical developing pan-amyloid removal therapeutics (antibody–peptide fusions) and pan-amyloid imaging agents (I‑124 PET, Tc‑99m SPECT) for systemic amyloidosis.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Attralus.
